1-6 of 6
Paula A Lengerke Diaz, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Management of Patients with Aggressive B Cell Non-Hodgkin Lymphoma after Relapse from Axicabtagene Ciloleucel: Single Center Real-World Experience

Jose V. Forero, MD, Paula A. Lengerke Diaz, MD, Eider F. Moreno Cortes, MD, Megan Melody, MD, Allison C. Rosenthal, D.O., Mohamed A. Kharfan-Dabaja, MDMBA, Januario E. Castro, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–44.
https://doi.org/10.1182/blood-2020-143168
Published: 2020
Journal Articles

Long-Term Sustained Responses Following Ibrutinib Discontinuation after Frontline Therapy with Obinutuzumab Plus Ibrutinib in Patients with Chronic Lymphocytic Leukemia

Paula A. Lengerke Diaz, MD, Michael Y. Choi, MD, Eider F. Moreno Cortes, MD, Jose V. Forero, MD, Juliana Velez-Lujan, PhD, Carlos I. Amaya-Chanaga, MD, Thomas Kipps, MDPhD, Januario E. Castro, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–34.
https://doi.org/10.1182/blood-2020-143473
Published: 2020
Journal Articles

Baseline Hypoalbuminemia Does Not Appear to be an Adverse Prognostic Factor in Patients with Relapse/Refractory B-Cell Lymphomas Treated with Axicabtagene Ciloleucel (axi-cel)

Megan Melody, MD, Sangeetha Gandhi, MBBS, Zaid Abdel Rahman, MD, Paula A Lengerke Diaz, MD, Nicole Gannon, PA-C, Allison C. Rosenthal, DO, Tuan Truong, Mattia Novo, Eva Brandes, Gina Lange, Breanna Estby, RN, Patrick Johnston, MD PhD, Stephen M Ansell, MD PhD, N. Nora Bennani, MD, Jonas Paludo, MD, Jose Villasboas, MD, Ernesto Ayala, MD, Han W. Tun, MD, Hemant S. Murthy, MD, Vivek Roy, MD, James M. Foran, MD, Januario E. Castro, MD, Yi Lin, MD PhD, Mohamed A Kharfan-Dabaja, MDMBA
Journal: Blood
Blood (2019) 134 (Supplement_1): 5343.
https://doi.org/10.1182/blood-2019-126594
Published: 2019
Journal Articles

Chimeric Antigen Receptor T Cell Therapy Pipeline at a Glance: A Retrospective and Systematic Analysis from Clinicaltrials.Gov

Eider F Moreno Cortes, MD, Caleb K Stein, PhD, Paula A Lengerke Diaz, MD, Cesar A Ramirez-Segura, BS, PhD, Januario E. Castro, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5629.
https://doi.org/10.1182/blood-2019-132273
Published: 2019
Journal Articles

Ibrutinib Reduces Obinutuzumab-Gazyva Infusion Related Reactions (IRR) in Patients with Chronic Lymphocytic Leukemia (CLL) and It Is Associated with Changes on Plasma Cytokine Levels

Juliana Velez Lujan, BS,PhD, Chaja Jacobs, MD, Paula A Lengerke Diaz, MD, Eider F Moreno-Cortes, MD, Cesar A Ramirez-Segura, BS, PhD, Michael Y. Choi, MD, Colin McCarthy, BS, Alaina Heinen, BS, Carlos Amaya-Chanaga, MD, Thomas J. Kipps, MD PhD, Januario E Castro, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1864.
https://doi.org/10.1182/blood-2018-99-119523
Published: 2018
Journal Articles

The Status of Multiple Myeloma in Colombia: First Report of the Colombian Registry for Hemato-Oncological Diseases (RENEHOC). Asociacion Colombiana De Hematologia y Oncologia (ACHO)

Virginia Abello, MD, Henry Idrobo, Claudia Lucia Sossa, Kenny Mauricio Galvez, MD, Domingo Saavedra, Maria Helena Solano, MD, Rigoberto Gomez, Lina Gaviria, MD, Jheremy Reyes, MD, Monica Osuna, Luis Antonio Salazar, MD, Angela María Peña, MD, Claudia Patricia Casas, MD, Daniel Espinosa, MD, Paula A Lengerke Diaz, MD, Januario E. Castro, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5597.
https://doi.org/10.1182/blood-2018-99-114927
Published: 2018